Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Non Operating Income (2019 - 2025)

OptimizeRx's Other Non Operating Income history spans 7 years, with the latest figure at $62000.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 63.16% year-over-year to $62000.0; the TTM value through Sep 2025 reached $177000.0, up 112.11%, while the annual FY2024 figure was $152000.0, 69.6% down from the prior year.
  • Other Non Operating Income for Q3 2025 was $62000.0 at OptimizeRx, up from $37000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $720419.0 in Q2 2023 and bottomed at -$1.6 million in Q4 2023.
  • The 5-year median for Other Non Operating Income is $38500.0 (2024), against an average of $92182.1.
  • The largest YoY upside for Other Non Operating Income was 22182300.0% in 2023 against a maximum downside of 392.3% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $2383.0 in 2021, then skyrocketed by 22498.07% to $538512.0 in 2022, then tumbled by 392.3% to -$1.6 million in 2023, then skyrocketed by 102.48% to $39000.0 in 2024, then skyrocketed by 58.97% to $62000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Other Non Operating Income are $62000.0 (Q3 2025), $37000.0 (Q2 2025), and $39000.0 (Q1 2025).